A cure for all ills? The effectiveness of therapeutic and biosimilar pharmaceutical competition in the Netherlands

Authors :: Ilan Akker
Wolf Sauter
Law, Markets and Behavior
Kooijmans Institute
Corporate Law
Source :: Sauter, W & Akker, I 2020, ' A cure for all ills? The effectiveness of therapeutic and biosimilar pharmaceutical competition in the Netherlands ', European Pharmaceutical Law Review, vol. 4, no. 1, pp. 57-66 . https://doi.org/10.21552/eplr/2020/1/8, European Pharmaceutical Law Review, 4(1), 57-66. Lexxion
Publication Year :: 2020

Subjects :: Competition (economics)
business.industry
Biosimilar
International trade
business

Language :: English
ISSN :: 25117157
Database :: OpenAIRE
Journal :: Sauter, W & Akker, I 2020, ' A cure for all ills? The effectiveness of therapeutic and biosimilar pharmaceutical competition in the Netherlands ', European Pharmaceutical Law Review, vol. 4, no. 1, pp. 57-66 . https://doi.org/10.21552/eplr/2020/1/8, European Pharmaceutical Law Review, 4(1), 57-66. Lexxion
Accession number :: edsair.doi.dedup.....089a742f097bfe6733deb16ae4b06292
Full Text :: https://doi.org/10.21552/eplr/2020/1/8

Full Text Access

Tools